ALUR
Allurion Technologies Inc

2,113
Mkt Cap
$12.87M
Volume
143,540.00
52W High
$16.81
52W Low
$1.29
PE Ratio
-0.19
ALUR Fundamentals
Price
$1.27
Prev Close
$1.39
Open
$1.45
50D MA
$1.91
Beta
1.03
Avg. Volume
50,911.96
EPS (Annual)
-$3.20
P/B
-0.13
Rev/Employee
$234,379.56
Loading...
Loading...
News
all
press releases
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the publication of a peer-reviewed, case-controlled study on the use of the Allurion Smart...
Business Wire·7h ago
News Placeholder
More News
News Placeholder
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a strategic distribution partnership with ProSurg Medical, a leading Brazilian medical device...
Business Wire·2d ago
News Placeholder
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion
Boston Scientific, Insulet, BioLife Solutions and Allurion push ahead with innovation and efficiency as the Medical Products industry faces pressure.
Zacks·3d ago
News Placeholder
4 Medical Product Stocks to Watch From a Challenging Industry
The Zacks Medical products industry sees steady demand, but macro headwinds keep growth under pressure in 2025. BSX, PODD, BLFS and ALUR reflect the favorable fundamentals.
Zacks·3d ago
News Placeholder
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced its financial results for the third quarter and provided a business update. Recent Company...
Business Wire·8d ago
News Placeholder
A Look at Allurion Technologies's Upcoming Earnings Report
read more...
Benzinga·9d ago
News Placeholder
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing
Allurion Technologies, Inc. (NYSE: ALUR) (Allurion or the Company), a pioneer in metabolically healthy weight loss, today announced it has passed critical milestones in the U.S. Food and Drug...
Business Wire·9d ago
News Placeholder
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025
Allurion Technologies, Inc. (Allurion or the Company) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that it will report financial results for the third quarter 2025 on...
Business Wire·14d ago
News Placeholder
Allurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates
Allurion Technologies, Inc. (ALUR) delivered earnings and revenue surprises of +12.31% and -43.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
BioLife Solutions (BLFS) delivered earnings and revenue surprises of +100.00% and +6.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago

Latest ALUR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.